Treatment Administration BPC 157 is typically administered via injection under medical guidance
These insights have led to therapeutic strategies targeting hypoxia and tumor metabolism, including HIF-2 inhibitors (e.g., belzutifan), hypoxia-activated prodrugs, anti-angiogenic agents, glycolysis and glutaminase inhibitors, lactate transport blockers, CAIX inhibitors, and immunometabolic modulators aimed at reversing hypoxia-induced immune suppression [ Table 1 ]
The physiological differences between men and women are investigated in the context of human evolution in the recent New York Times bestseller: Eve How the Female body Drove 200 Million Years of Human Evolution, by Cat Bohannon (Knopf, New York, 2024)
Hu M, Yuan L, Zhu J (2024) The dual role of NRF2 in colorectal cancer, targeting NRF2 as a potential therapeutic approach
415 VIT-2763 is under development as an oral medication targeting FPN for -thalassemia treatment